This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Hepatitis


  • Summit Harnesses Global Momentum to Eliminate Viral Hepatitis
    Participants at the first-ever World Hepatitis Summit will urge countries to develop national programs that can ultimately eliminate viral hepatitis as a problem of public health concern. “We know how to prevent viral hepatitis, we have a safe and effective vaccine ...More
    3 days ago Posted in News
  • 1 in 4 Hepatitis C Patients Denied Initial Approval for Drug Treatment
    Nearly 1 in 4 patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study. The finding, published Aug. 27 in PLOS ONE, identifies a new barrier to ...More
    2 weeks ago Posted in News
  • Hepatitis A-Like Virus Identified in Seals
    Scientists in the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provides new clues on the emergence of hepatitis ...More
    2 weeks ago Posted in News
  • Expression of a Single Gene Lets Scientists Grow Hepatitis C Virus in the Lab
    Worldwide, 185 million people have chronic hepatitis C. Since the late 1980s, when scientists discovered the virus that causes the infection, they have struggled to find ways to grow it in human cells in the lab -- an essential part of learning how the virus works and ...More
    3 weeks ago Posted in News
  • Hepatitis C Infection May Fuel Heart Risk
    People infected with the hepatitis C virus are at risk for liver damage, but the results of a new Johns Hopkins study now show the infection may also spell heart trouble. The findings, described online July 27 in the Journal of Infectious Diseases, emerged from a larger ...More
    4 weeks ago Posted in News
  • Urban ERs See High Rates of Hepatitis C Infection
    An urban emergency department that set up a hepatitis C testing protocol saw high rates of infection among intravenous drug users and Baby Boomers, with three-quarters of those testing positive unaware they were infected. The results of a screening and diagnostic testing ...More
    4 weeks ago Posted in News
  • Hepatitis B Continues to be a Global Health Problem
    Hepatitis B infections are among the most common infectious diseases worldwide. The disease can become chronic, and is one of the most important causes of severe diseases such as liver cancer. In the scope of an international study funded by the World Health Organization, ...More
    July 28, 2015 Posted in News
  • FDA Approves New Treatment for Chronic Hepatitis C Genotype 3 Infections
    The Food and Drug Administration (FDA) has approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV infections without the ...More
    July 24, 2015 Posted in News
  • WHO Calls for Urgent Action to Curb Hepatitis
    On World Hepatitis Day, July 28, 2015, the World Health Organization (WHO) highlights the urgent need for countries to enhance action to prevent viral hepatitis infection and to ensure that people who have been infected are diagnosed and offered treatment. This year, ...More
    July 24, 2015 Posted in News
« Previous12345678910115758Next »